Testosteron-Mepha 1000 mg / 4 ml
Testosteron-Mepha 1000 mg / 4 ml is a medicine authorised by Swissmedic under authorisation number 68989. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 November 2023 and the authorisation is limited until 27 November 2028. ATC code G03BA03 places the medicine in the group Sex hormones and modulators of the genital system.
| Authorisation number | 68989 |
|---|---|
| Name | Testosteron-Mepha 1000 mg / 4 ml |
| Full name | Testosteron-Mepha 1000 mg / 4 ml, Injektionslösung |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G03BA03 |
| First authorisation | 28 November 2023 |
| Authorisation validity | 27 November 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Testosteron-Mepha 1000 mg / 4 ml, Injektionslösung | B | 28 November 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | G03BA03 | 07.08.4. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Testosteron-Mepha 1000 mg / 4 ml authorised in Switzerland?
Yes. Testosteron-Mepha 1000 mg / 4 ml is authorised by Swissmedic under authorisation number 68989, data as of 01 September 2026. The authorisation is limited until 27 November 2028.
Which dispensing category does Testosteron-Mepha 1000 mg / 4 ml have?
Testosteron-Mepha 1000 mg / 4 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Testosteron-Mepha 1000 mg / 4 ml?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.